Reuters logo
BRIEF-Chiasma announces first patient is randomized in phase 3 trial of Octreotide capsules in patients with acromegaly
September 27, 2017 / 8:22 PM / 3 months ago

BRIEF-Chiasma announces first patient is randomized in phase 3 trial of Octreotide capsules in patients with acromegaly

Sept 27 (Reuters) - Chiasma Inc

* Chiasma announces first patient is randomized in phase 3 chiasma optimal clinical trial of Octreotide capsules in patients with acromegaly

* Chiasma Inc - Meeting its previous guidance that enrollment in study would begin during second half of 2017​

* Chiasma Inc - ‍Announced it has recently surpassed 50% patients randomized in its international phase 3 clinical trial​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below